Robert Francomano - Chief Commercial Officer at SELLAS Life Sciences Group, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Issuer Symbol
SLS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert Francomano since 05 Jan 2025

Holdings reported by Robert Francomano for SELLAS Life Sciences Group, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 40,918 $255,774 $6.25 22 Jan 2024 Direct
Class A Common Stock 20,918 $22,591 $1.08 06 Dec 2023 Direct
Stock Option (Right to Buy) 30,000 22 Jan 2024 Direct Common Stock

Transactions reported by Robert Francomano for SELLAS Life Sciences Group, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.